Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Acquired Immunodeficiency Syndrome × liposomal doxorubicin × Clear all

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Wilms Tumor 1 Sarcoma, Kaposi 1 Sarcoma 1 Ovarian Neoplasms 1 Liposarcoma 1 Hodgkin Disease 1 Her2-negative Metastatic Breast Cancer 1 Acquired Immunodeficiency Syndrome 1 AIDS-related Kaposi sarcoma 1

Interventions

liposomal doxorubicin 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 3 Not yet recruiting

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡